Guidance for Cardlytics (CDLX)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| Q1 2024 | N/A | N/A | $70.00M – 73.00M | $66.46M | = Maintained | Details |
| Q2 2022 | N/A | N/A | $73.00M – 80.00M | $74.70M | = Maintained | Details |
| 2021 | N/A | N/A | $250.00M – 275.00M | $255.59M | = Maintained | Details |
| 2021 | N/A | N/A | $247.00M – 257.00M | $253.00M | = Maintained | Details |
| Q3 2021 | N/A | N/A | $57.00M – 66.00M | $71.00M | = Maintained | Details |
| Q1 2021 | N/A | N/A | $47.00M – 53.00M | $50.07M | = Maintained | Details |
| Q1 2020 | N/A | N/A | $43.50M – 46.50M | N/A | = Maintained | Details |
| 2019 | N/A | N/A | $195.00M – 200.00M | $190.49M | = Maintained | Details |
| Q4 2019 | N/A | N/A | $55.00M – 59.00M | $55.74M | = Maintained | Details |
| Q1 2019 | N/A | N/A | $34.50M – 36.50M | $41.79M | = Maintained | Details |
| 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| 2018 | N/A | N/A | $153.00M – 156.00M | $154.80M | = Maintained | Details |
| Q3 2018 | N/A | N/A | $36.00M – 38.00M | $37.85M | = Maintained | Details |
| Q2 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
